All articles by Staff Writer
Staff Writer
Detection of intrathecal antibodies in CNS diseases
The investigation of antibodies against pathogenic agents in cerebrospinal fluid samples is an important tool in the diagnosis of acute or chronic inflammation of the central nervous system. EUROIMMUN offers a range of ELISAs for determination of intrathecal antibodies in CSF and serum pairs, complemented by software for fully automated evaluation of results.
Identifying Microorganisms effectively
Faced with a rapidly increasing workload and the growing threat of antimicrobial resistance, clinical laboratories must find a new way to manage rising sample volumes and varieties while maintaining full confidence in the results. The easy to use, Bruker MALDI Biotyper sirius IVD System facilitates fast microbial identification at high throughput rates to support accelerated clinical decisions and improved patient treatment schedules. Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) is now considered the industry standard for species-level microorganism identification.
Testing for vaginitis disorders
Slow diagnosis can exacerbate sexually transmitted infections. What is needed is a fast and accurate method of diagnosing conditions such as trichomoniasis and bacterial vaginosis, which is what SEKISUI Diagnostics aims to provide.
Detection of Group B strep in pregnant women
Neonatal sepsis affects a large amount of newborns, which is why it is imperative to identify as quickly and accurately as possible. Uniogen’s kit can do just this, detecting the genome and allowing steps to be taken.
Prime target
Genomic sequencing allows doctors to identify mistakes in the instructions that can lead to diseases, but what if there’s none to be found? Proteomics – the study of proteins, their interactions, functions and cellular activities – is providing a new avenue for diagnosing certain conditions, as researchers continue to identify biomarkers that present alongside them. Monica Karpinski speaks to Dr Luigi Ferrucci, scientific director of the National Institute of Ageing, and Dr Christoph Borchers, professor of oncology at McGill University and director at Segal Cancer Proteomics Centre, to find out why proteomics is considered by some as the next frontier in personalised medicine.
Design and development of a medicine platform with a 5P (predictive, preventive, personalised, participatory and populational) approach through massive sequencing (NGS)
Certest Biotec, a biotech company based in San Mateo de Gállego, is committed to R&D as a driving force for development and growth. The company is currently immersed in a process of evolution and transition to the biopharma sector with the development of new research projects that combine various scientific disciplines such as biotechnology, bioinformatics, chemistry, biochemistry and nanotechnology.
bioMérieux launches BIOFIRE FIREWORKS a cutting-edge, data-driven software solution that takes BIOFIRE Systems to the next level
bioMérieux, a world leader in the field of in vitro diagnostics, launches BIOFIRE® FIREWORKS™, an innovative and integrated software solution for BIOFIRE® Systems optimizing laboratory services and supporting data-driven decisions. This software is the newest addition to the BIOMÉRIEUX VISION SUITE – the company’s portfolio of Data and IT Solutions supporting increased efficiency and productivity in laboratories worldwide.
Sirius Medical announces major funding round to further accelerate sales growth and new product development
EINDHOVEN, Netherlands, March 28, 2023 /PRNewswire/ — Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The funding will accelerate the worldwide growth of their product Pintuition and support further product development. Holland Capital acted as lead investor for this series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, and a major investment from Sirius Medical’s management and team. Norgine Ventures joined as a new investor in this round to support further commercial roll-out. Sirius’ state-of-the-art navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and more than 5,000 successful Pintuition procedures across Western Europe and the US, the company experienced an unprecedented growth in revenue in 2022, attributable to Pintuition’s ease of use, straightforward implementation, and its unmatched precision in locating the target tissue.
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop a new genomic assay. This new next-generation sequencing (NGS) test will build on Acutis Diagnostics’ track record of approved lab-developed tests that support clinical trials, cancer research and treatment.
Propanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancer
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that PRP suppresses the TGF-β pathway and the tumor microenvironment in pancreatic cancer, elucidated by one of the Company’s joint researchers, Mrs. Belén Toledo Cutillas MSc, at the laboratory of Professor Macarena Perán, PhD, University of Jaén, Granada, Spain. The experiments were conducted with a well-known small molecule inhibitor of the same pathway, comparing it against the effects of PRP, with results showing an even greater suppression by Propanc’s novel cancer therapy. TGF-β is a growth factor molecule involved in cell proliferation, migration and survival, and death that influences tumor growth in advanced forms of cancer.